Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19

NCT05778318 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05778318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05778318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 20, 2023
Completion date
June 30, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia